Yang H - Search Results

1

Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer.

Yuan K, Shen H, Zheng M, Xia F, Li Q, Chen W, Ji M, Yang H, Zhuang X, Cai Z, Min W, Wang X, Xiao Y, Yang P. Yuan K, et al. Among authors: yang p, yang h. J Med Chem. 2023 Mar 23;66(6):4215-4230. doi: 10.1021/acs.jmedchem.3c00106. Epub 2023 Feb 17. J Med Chem. 2023. PMID: 36800260

2

Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects.

Xu S, Guo A, Chen NN, Dai W, Yang HA, Xie W, Wang M, You QD, Xu XL. Xu S, et al. Eur J Med Chem. 2021 Nov 5;223:113604. doi: 10.1016/j.ejmech.2021.113604. Epub 2021 Jun 9. Eur J Med Chem. 2021. PMID: 34174740

3

Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer.

Chen W, Ji M, Cheng H, Zheng M, Xia F, Min W, Yang H, Wang X, Wang L, Cao L, Yuan K, Yang P. Chen W, et al. Among authors: yang p, yang h. J Med Chem. 2022 Nov 24;65(22):15102-15122. doi: 10.1021/acs.jmedchem.2c00947. Epub 2022 Nov 9. J Med Chem. 2022. PMID: 36350721

4

Targeting polyketide synthase 13 for the treatment of tuberculosis.

Xia F, Zhang H, Yang H, Zheng M, Min W, Sun C, Yuan K, Yang P. Xia F, et al. Among authors: yang p, yang h. Eur J Med Chem. 2023 Nov 5;259:115702. doi: 10.1016/j.ejmech.2023.115702. Epub 2023 Aug 1. Eur J Med Chem. 2023. PMID: 37544185 Review.

5

Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer.

Yuan K, Xia F, Li Q, Zheng M, Shen H, Chen W, Yang H, Zhuang X, Zhang XY, Xiao Y, Yang P. Yuan K, et al. Among authors: yang p, yang h. J Med Chem. 2023 Dec 14;66(23):16235-16256. doi: 10.1021/acs.jmedchem.3c01626. Epub 2023 Nov 30. J Med Chem. 2023. PMID: 38033250

6

Molecules inducing specific cyclin-dependent kinase degradation and their possible use in cancer therapy.

Zheng M, Zhang XY, Chen W, Xia F, Yang H, Yuan K, Yang P. Zheng M, et al. Among authors: yang p, yang h. Future Med Chem. 2024 Feb;16(4):369-388. doi: 10.4155/fmc-2023-0259. Epub 2024 Jan 30. Future Med Chem. 2024. PMID: 38288571 Review.

7

Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment.

Min W, Yang H, Wang D, Chen C, Wang Y, Hou Y, Zhu Y, Sun C, Wang X, Yuan K, Yang P. Min W, et al. Among authors: yang p, yang h. J Med Chem. 2024 Jul 25;67(14):12314-12330. doi: 10.1021/acs.jmedchem.4c01004. Epub 2024 Jul 4. J Med Chem. 2024. PMID: 38962837

8

PtAu-Carbon Nanotube/Glassy Carbon Electrode Composite based Electrochemical Sensor for High-Precision Detection of Tetracycline.

Du Y, Wang Y, Liu T, Yang H, Huang C. Du Y, et al. Among authors: yang h. Chempluschem. 2025 Jan 27:e202400525. doi: 10.1002/cplu.202400525. Online ahead of print. Chempluschem. 2025. PMID: 39871001

9

Research on the impact of the digital economy on carbon emissions based on the dual perspectives of carbon emission reduction and carbon efficiency.

Liu X, Chen L, Lu Y, Chang M, Xiao Y, Yang H, Kong D, Zhang L. Liu X, et al. Among authors: yang h. Sci Rep. 2025 Jan 27;15(1):3416. doi: 10.1038/s41598-025-87098-1. Sci Rep. 2025. PMID: 39870757 Free article.

10

Long-term surgical outcomes of esotropic duane retraction syndrome type 1.

Park J, Yang HK, Hwang JM. Park J, et al. Among authors: yang hk. Sci Rep. 2025 Jan 27;15(1):3358. doi: 10.1038/s41598-024-78738-z. Sci Rep. 2025. PMID: 39870649 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,667 results

Search Page

Filters